06/12/2025
3:51 PM | Adaptive Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2025
12:40 PM | Adaptive Biotechnologies (Subject)
ARK Investment Management LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/20/2025
6:46 PM | Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
| Form 4/A | |
05/19/2025
6:59 PM | Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
9:34 AM | Adaptive Biotechnologies (Subject)
ARK Investment Management LLC (Filed by)
| Form SCHEDULE 13G | |
05/07/2025
10:42 AM | Adaptive Biotechnologies (Subject)
ARK Investment Management LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/01/2025
4:38 PM | Adaptive Biotechnologies (Subject)
ROBINS HARLAN S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2025
3:15 PM | Adaptive Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2025
3:13 PM | Adaptive Biotechnologies (Filer)
| Form ARS | |
03/26/2025
5:48 PM | Adaptive Biotechnologies (Issuer)
ROBINS HARLAN S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2025
4:45 PM | Adaptive Biotechnologies (Subject)
ROBINS HARLAN S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for ADPT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Adaptive Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. |
03/17/2025
6:33 PM | Adaptive Biotechnologies (Issuer)
GRIFFIN MICHELLE RENEE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
6:34 PM | Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2025
4:28 PM | Adaptive Biotechnologies (Subject)
GRIFFIN MICHELLE RENEE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2025
6:48 PM | Adaptive Biotechnologies (Issuer)
HERSHBERG ROBERT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
6:47 PM | Adaptive Biotechnologies (Issuer)
NEUPERT PETER M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
4:30 PM | Adaptive Biotechnologies (Subject)
HERSHBERG ROBERT (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
1:48 PM | Adaptive Biotechnologies (Subject)
NEUPERT PETER M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2025
6:14 PM | Adaptive Biotechnologies (Issuer)
GRIFFIN MICHELLE RENEE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
6:15 PM | Adaptive Biotechnologies (Issuer)
HERSHBERG ROBERT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
6:16 PM | Adaptive Biotechnologies (Issuer)
NEUPERT PETER M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
6:16 PM | Adaptive Biotechnologies (Issuer)
OWEN KATEY EINTERZ (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
6:17 PM | Adaptive Biotechnologies (Issuer)
Pellini Michael J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
6:17 PM | Adaptive Biotechnologies (Issuer)
ROBINS CHAD M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
6:18 PM | Adaptive Biotechnologies (Issuer)
ROBINS HARLAN S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
6:19 PM | Adaptive Biotechnologies (Issuer)
RUBINSTEIN JULIE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
6:20 PM | Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
6:21 PM | Adaptive Biotechnologies (Issuer)
BENZENO SHARON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
6:22 PM | Adaptive Biotechnologies (Issuer)
BOBULSKY SUSAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
6:22 PM | Adaptive Biotechnologies (Issuer)
LO FRANCIS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:10 PM | Adaptive Biotechnologies (Subject)
GRIFFIN MICHELLE RENEE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
3:36 PM | Adaptive Biotechnologies (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/21/2025
6:28 PM | Adaptive Biotechnologies (Issuer)
ROBINS CHAD M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
3:51 PM | Adaptive Biotechnologies (Subject)
ROBINS CHAD M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/18/2025
7:21 PM | Adaptive Biotechnologies (Issuer)
ROBINS CHAD M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
10:23 AM | Adaptive Biotechnologies (Subject)
ARK Investment Management LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/13/2025
4:11 PM | Adaptive Biotechnologies (Subject)
ROBINS CHAD M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2025
1:20 PM | Adaptive Biotechnologies (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
02/04/2025
5:13 AM | Adaptive Biotechnologies (Subject)
Sumitomo Mitsui Trust Group, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
01/27/2025
3:00 PM | Adaptive Biotechnologies (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
| Form SCHEDULE 13G/A | |
11/19/2024
5:45 PM | Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad) Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.”
We recently sat down with Rickards to capture all the key details on tape.
 For the moment, you can watch this interview free of charge – just click here. |
11/13/2024
3:30 PM | Adaptive Biotechnologies (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G | |
11/13/2024
8:00 AM | Adaptive Biotechnologies (Subject)
Matrix Capital Management Company, LP (Filed by)
| Form SC 13G/A | |
11/12/2024
12:30 PM | Adaptive Biotechnologies (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/08/2024
2:15 PM | Adaptive Biotechnologies (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
| Form SC 13G | |
11/07/2024
3:30 PM | Adaptive Biotechnologies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
5:07 AM | Adaptive Biotechnologies (Subject)
Sumitomo Mitsui Trust Group, Inc. (Filed by)
| Form SC 13G | |
11/04/2024
9:58 AM | Adaptive Biotechnologies (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G | |
10/11/2024
3:14 PM | Adaptive Biotechnologies (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
| Form SC 13G/A | |
10/10/2024
4:47 PM | Adaptive Biotechnologies (Issuer)
BOBULSKY SUSAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
3:27 PM | Adaptive Biotechnologies (Issuer)
Taylor Stacy L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:18 PM | Adaptive Biotechnologies (Subject)
Taylor Stacy L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
3:30 PM | Adaptive Biotechnologies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
3:15 PM | Adaptive Biotechnologies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
